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Abstract 
Background: The present study characterizes the socio-demographic variables of injection drug users (IDUs) 
attending Oral substitution therapy (OST) center. Aims & Objectives: To provide a comprehensive knowledge and 
better insight regarding the socio-demographic profile and pattern IDUs. Material & Methods: A total of 158 IDUs 
aged 18 to 60 years who attended the OST centre during one-year period at a government medical college are 
included in the study. Results: All the IDUs are male with median age of 33.13 years. More than half of the 
participants are homeless and earn their livelihood by rag picking and rickshaw driving. 35.4% of participants are 
married. Their mean monthly income is Rs 2823.4 ± 1811.8 and they spend a major amount of it on drug use. 
Conclusion: All the participants are using Pharmaceutical Opioid injections (POI), mostly as cocktail with 
benzodiazepines and antihistamines. Sharing of needle and paraphernalia is present in most of the participants 
especially among the illiterate and low income group IDUs. 
Keywords  
Injection drug users; POIs; Oral substitution therapy; unsafe injection practices; high risk behavior. 
Introduction  
Injection drug use (IDU) is one of the major problems 
of modern society in both developed and developing 
countries. There are about 15.9 million (range 11.0-
21.2 million) injection drug users (IDUs) across the 
world (1,2). In South, East & South-East Asia Region 
there are approximately 3.9 million (range 3.5–5.6 
million) IDUs and HIV prevalence in them ranges 
from 10 to 43%414.0 million people between the 
ages of 15 and 64 are estimated to be injecting drugs, 
while 1.6 million people who inject drugs are living 
with HIV (3). In India there are around 177,000 IDUs 
with an estimated HIV prevalence of 7.1%. (5) 
Despite of various other modes of drug intake, 
Injection of drugs is favored by some users because 
of greater availability of drug that can be injected, 
cheaper cost, more rapid action, no loss of the drug 
in smoke, production locations and trafficking 
routes, migrating drug users sharing knowledge and 
techniques (6) It  bypasses first-pass metabolism in 
the liver, resulting in a higher bioavailability, and 
shorter, more intense high that can lead to a 
dependency developing more quickly than with 
other methods of taking drugs.  
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IDU adversely effects individual, family and 
community resulting in low self-esteem, social 
withdrawal and disharmony, economic setbacks, 
domestic abuse and crime (7). High risk behavior 
(unsafe injection practices, using and sharing dirty 
needles and paraphernalia, risky sexual behaviour 
for drug exchange) associated with IDU facilitates 
the transmission of infections particularly HIV and 
hepatitis (3) and considerably increases (13 - 38 
times) the morbidity and mortality than general 
population (8,9).  Only 5.6% of IDUs in India are 
receiving opioid substitution therapy with 
buprenorphine (10).  
IDUs are at an increased risk of various medical and 
psychiatric disorders and have poor quality of life.  
Aims & Objectives 
To provide a comprehensive knowledge and better 
insight regarding the socio-demographic profile and 
pattern IDUs. 
Material & Methods 
This cross sectional was conducted among all the 
new IDUs of age > 18 years and <60yrs of age, of 
either sex attending the Opioid Substitution Therapy 
[O.S.T.] centre in Sarojini Naidu Medical College 
(SNMC), Agra for one-year period from April 2014 to 
March 2015, and have injected drugs at least once in 
past 3 months have been included in the study after 
taking written informed consent. Each IDU is 
interviewed in detail by separate questionnaires 
regarding socio-demographic parameters 
(Kuppuswami scale), pattern, type and frequency of 
drug used in injection.  
Inclusion criteria: Age 18 to 60 yrs, those IDUs of 
one-year duration, current IDUs (who have injected 
drugs at least once in last 3 months), those giving 
consent to participate in study.  
Exclusion criteria: age <18 and >60yrs, pregnant and 
lactating women. 
Ethical Clearance: The study was approved by the 
ethical committee as post graduate thesis. 
Results 
A total of 158 IDUs are enrolled in the study and all 
of the participants are male as none of the female 
IDUs have attended the OST centre during the study 
period. As shown in (Table 1) most of the participants 
were less than 40 years of age, urban resident and 
64.6% of them are unmarried, divorced or separated. 
Most of the IDUs are of lower educational status and 
educated up to primary or middle school. 63.3% of 
the participants are unskilled worker and 50% of the 
IDUs are homeless and live on the street. Most of the 
IDUs spent 51-75% of their income on drug use and 
10.8% of the participants are unemployed are totally 
dependent on the family and friends for their 
financial expenses related to drug use and other 
chores (Table 2). As shown in (Table 3), 86.1% of IDUs 
are of upper-lower socio-economic status. 50% of 
the participants are using injection drug for last 4-6 
years with mean duration of use of 4.9 ±2.9 years 
(Table 4). As shown in (Table 5) all the participants 
are using a combination of a pharmaceutical opioid 
injection (POI) mostly in combination with 
benzodiazepine or antihistamine and only 20.9% of 
IDUs are using POI alone. Sharing of needle and 
paraphernalia is present in 57% of the IDUs mostly 1-
3 times in 10 injecting practices (Table 6). Sharing of 
needles and paraphernalia is more commonly seen 
in younger age groups (18-30 years) 65% which 
contributed to 50% of overall needle sharing, 
illiterate, low income group and unemployed 
participants (Table 7, Table 8 & Table 9). 
Discussion  
A total of 158 IDUs who have attended the OST 
centre in SN Medical College, Agra are included in 
the study. As shown in Table 1, most of the IDUs 
(~82) belong to 18-40 years of age with mean age of 
33.13 ± 9.19 years, and only 12.6 of them were aged 
45 years or older. In a study conducted by Armstrong 
et al (11) in 2013 among 420 male IDUs at Delhi 
found that mean age of participants was 36.7 years 
and one quarter (26) aged 45 or older. Medhi et al 
(12) described that the typical IDUs in India are male; 
aged between 15 and 35 & only. Mean age of first 
illicit drug injection in our participants is 28.2 ± 8.8 
years (13,14). So the most productive years of life of 
an IDU are wasted due to drug abuse. After 40 years 
of age tendency to dependent on opioids remit 
spontaneously and has been called “maturing out” 
(15).  
35.4% of our participants are married, rest are 
unmarried, divorced or separated. In a study by Sarin 
(16) and colleagues on 449 IDUs in New Delhi shows 
that 35% of the participants were married, but only 
26% lived with their spouses and rest were 
separated. In another study by Kermode et al (13) on 
IDUs in Nagaland shows that 66% were single and 
34% were married. It might be because IDUs spent 
most of their time and money in drug use and are 
unable to fulfill their social responsibilities.    
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Most of the participants in our study are either 
illiterate or of lower educational status and only 
10.7% of the participants have passed high school as 
is shown in previous studies Kermode et al (13), 
Ambekar et al (17). 63.3% of the IDUs are unskilled 
worker and earn their livelihood mainly by rag 
picking and rickshaw driving. Sarin et al (16), 
Solomon et al (18) and Ambekar et al (19) shows that 
rag picking is the main occupation of IDUs in India 
and only few have respectable jobs or business. 
Mean monthly income of IDUs in the present study 
was Rs 2823.4 ± 1811.8, as is the income of IDUs of 
New Delhi (23) (less than Rs 100 a day) and of 
Manipur and Nagaland 13 (mean=Rs 3662/month, 
median= Rs 3000/ month, SD=31.3). Most of the 
participants spent substantial amount of their 
income on injection and paraphernalia (mean =Rs 
2153.2 ± 818.8 per month) and it shows positive 
correlation with their monthly income. 52.5% of our 
participants are currently (in last 3 months) 
homeless and live on the street. These are mostly rag 
pickers and rickshaw drivers. Sarin et al (21), 
Ambekar et al (19), Armstrong et al (22), have also 
shown that 60-70% of the IDUs in India are homeless 
and others mostly have poor living arrangement.  
In India here is geographical variation in type of 
Opioids used for injection (23,24). Although heroin 
injecting is reported from the northeastern states as 
well as the metropolitan cities, Pharmaceutical 
Opioid Injecting (POI) has been reported from other 
states of India. All of our participants were using POI. 
87.3% (N=138) were using injection buprenorphine 
and rest 12.7% (N=20) were using injection 
pentazocine. 79% of the IDUs combine POI with 
injection diazepam and/or pheniramine in various 
fractions and combinations (the so called “South 
Asian Cocktail”) (25), and only 21% were using it 
alone. They get these drugs from certain specific 
drug stores and chemist shops. 56.3% of our 
participants were injecting daily and 29.8% three to 
four days per week. Similar pattern of drug use was 
reported by Sarin et al (16), Ojha et al (25), 
Armstrong et al (22) and Ambekar et al (17).  POIs are 
the predominant type of Opioids injected in India. 
Almost every state, with the exception of Manipur, 
reported injecting one or the other POI. This might 
be because POIs are cheaper than heroin in India 
(26). Most of these POIs are procured from 
neighborhood pharmacy shops without medical 
prescription due to lax mechanisms regulating 
pharmaceutical sales (27) and is safer than obtaining 
heroin from a drug dealer, which can be associated 
with dangers, including getting arrested or landing 
into other legal problems.  
Sharing of needle and paraphernalia is seen in 57% 
of our participants. Most of the participants share 1-
3 times in 10 injecting practices in last 3 months and 
many of them share used, re-used and even 
discarded needles & syringes. Most of them shared 
only with close friends and regular injecting partners. 
Sharing is more among the low income group IDUs 
and illiterate participants. Most of the IDUs procure 
needles and syringes from friends and chemist 
shops. They must be properly informed about the 
needle syringe exchange program (NSEP) and 
educated about needle sharing, needle hygiene and 
safe acquisition and disposal 
Conclusion 
Thus all the participants in our study were males, 
with a mean age of 33.13 ± 9.19 years. Most of them 
were of lower educational & socio-economic status; 
their main occupation was rag picking & rickshaw 
driving and majority of them were homeless. All of 
them were using POI (buprenorphine or 
pentazocine), mostly along with diazepam and / or 
pheniramine making a cocktail. Sharing of injection 
and paraphernalia was present in 57 of the 
participants, mostly among young, illiterate and low 
income group participants and proper education and 
information to the target population might help to 
reduce the harm caused by illicit drug injection 
Recommendation 
1. Opening of more oral substitution therapy (OST) 
centers at the district level and at high risk sites, 
maintaining the anonymity of subjects and free 
distribution of syringes and needles will help to 
tackle the problem of IDUs. 
2. Psychological evaluation of these patients for 
behavioural therapy can be done at OST centres. 
Limitation of the study 
1. It’s a hospital based study and only those IDUs 
could be accessed who themselves attended the 
OST centre 
2. Effect of drug could not be assessed as it was an 
observational study 
Relevance of the study 
Studying socio-demographic variables of IDUs will 
lead to better understanding of the who’s and why’s 
of the Injectable drug use in India and will be helpful 
in planning useful studies on the subject 
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Tables 
TABLE 1  DISTRIBUTION OF STUDY PARTICIPANTS AND SOCIO DEMOGRAPHIC VARIABLES 
AGE GROUP Frequency (n) (N=158) Percentage (%) 
18-30yrs 71 44.9 
31-40yrs 59 37.3 
41-50yrs 18 11.4 
51-60yrs 10 6.3 
RELIGION   
HINDU 137 86.7 
MUSLIM 21 13.3 
LOCATION   
URBAN 123 77.8 
RURAL 35 22.2 
MARITAL STATUS   
Married 56 35.4 
Unmarried 76 48.1 
Divorced or Separated 26 16.5 
EDUCATION   
Illiterate 59 37.3 
Primary school 56 35.4 
Middle school 26 16.5 
High school 9 5.7 
Intermediate 6 3.8 
Graduate or post graduate 2 1.3 
Professional 0 0 
OCCUPATION   
Unemployed 17 10.8 
Unskilled worker 100 63.3 
Semi skilled worker 31 19.6 
Skilled worker 5 3.2 
Clerical, shop owner, farmer 4 2.5 
Semi professional 1 0.6 
Professional 0 0 
LIVING ARRANGEMENT   
JOINT FAMILY 24 15.2 
NUCLEAR FAMILY 32 20.3 
ALONE AT HOME 10 6.3 
AT WORK PLACE 9 5.7 
HOMELESS 83 52.5 
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TABLE 2  PORTION OF INCOME SPENT ON INJECTABLE DRUGS AND SYRINGES 
Percentage of income spent on IDU Frequency  Percentage  
≤25% 8 5.1                                        5.1% 
26-50% 30 19 
51-75% 46 29.1 
76-100% 35 22.2 
101-150% 14 8.9 
151-200% 4 2.5 
>200% 4 2.5 
Borrowers * 17 10.8 
*  who did not earn on their own and borrowed money from friends or family members 
 
 
TABLE 3  SOCIO-ECONOMIC STATUS OF INJECTION DRUG USERS 
SES Frequency  Percent  
Lower 13 8.2 
Upper-lower 136 86.1 
Lower-middle 8 5.1 
Upper-middle 1 0.6 
 
 
TABLE 4  DURATION OF INJECTION DRUG USE 
DURATION (years of use) FREQUENCY PERCENTAGE  
1-3 YEARS 49 31.01 
4-6 YEARS 79 50 
7-9 YEARS 20 12.6 
10-12 YEARS 7 4.4 
>12 YEARS 3 1.9 
TOTAL 158 100 
 
 
TABLE 5  PATTERN OF DRUG USED BY INJECTION DRUG USERS 
DRUG USED FREQUENCY PERCENTAGE  
BUPRENORPHINE+ DIAZEPAM+PHENIRAMINE 77 48.7 
BUPRENORPHINE+ DIAZEPAM 18 11.4 
BUPRENORPHINE+ PHENIRAMINE 30 19.0 
BUPRENORPHINE 13 8.2 
PENTAZOCINE 20 12.7 
TOTAL 158 100 
 
TABLE 6  FREQUENCY OF NEEDLE & PARAPHERNALIA SHARING (NUMBER OF TIMES IN 10 
INJECTING EPISODES) 
NUMBER OF TIMES IN 10 INJECTING EPISODES FREQUENCY (n) PERCENTAGE (%) 
1 19 12 
2 31 19.6 
3 23 14.6 
4 9 5.7 
5 8 5.1 
Not sharing 68 43 
TOTAL 158 100 
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TABLE 7 RELATION OF AGE WITH SHARING OF NEEDLES,  SYRINGES OR OTHER EQUIPMENTS 
 
TABLE 8  SHARING OF NEEDLE WITH EDUCATION 
 Education Chi square df Asymptomatic significance 
Illiterate  Literate  
Sharing of needle and syringe No 16 52 9.734 1 0.02* 
Yes 43 47 
*Significant at 0.05 level **Significant at 0.01 level 
 
TABLE 9  FREQUENCY OF SHARING NEEDLE WITH INCOME OF THE STUDY PARTICIPANTS 
 Frequency of sharing in 10 injecting practices Chi-square df Asymptomatic significance 












No income 6 0 4 4 3 0 
Upto 2000 11 6 11 11 5 5 
>2000-4000 31 8 14 8 1 3 
>4000 20 5 2 0 0 0 




Sharing of needle and paraphernalias* Chi-square 




18-30  25 46 
31-40 30 29 
41-50 8 10 
51-60 5 5 
*equipment’s sharing 
